Table S4 from Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer

Abstract

<p>Demographics of TRIBE2 RCT cases used in this study compared with the full trial.</p>